Pharmaceutical and life sciences companies have historically been rare participants before the International Trade Commission (ITC) – in some cases, due to the stringent economic domestic industry ...
The Court of Appeals for the Federal Circuit issued an en banc opinion today finding that induced infringement may form the basis for an investigation of unfair import practices at the International ...